Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Bard

Showing results (11-20 of 107) with videos related to

Pageof 11
Sort By:
Clinical Chemistry|June 1, 1993
Sequential ultracentrifugation micromethod for separation of serum lipoproteins and assays of lipids, apolipoproteins, and lipoprotein particlesT Brousseau, V Clavey, J M Bard, et al.
The American Journal of Medicine|June 6, 1994
Fluvastatin reduces levels of plasma apo B-containing particles and increases those of LpA-I. European Fluvastatin Study GroupJ Dallongeville, J C Fruchart, P Pfister, et al.
Journal of Internal Medicine. Supplement|January 1, 1994
Effect of fluvastatin on plasma apolipoprotein-B-containing particles, including lipoprotein(a). European Fluvastatin Study GroupJ Dallongeville, J C Fruchart, P Pfister, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|September 1, 1987
[Molecular analysis of atherogenic and protective lipoproteins]J C Fruchart, J M Bard, C Fievet, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|June 30, 2009
Development and validation of an improved liquid chromatography-mass spectrometry method for the determination of pemetrexed in human plasmaC Bobin-Dubigeon, M B Amiand, C Herrenknecht, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|February 5, 2013
The anti-proliferative and pro-apoptotic effects of the trans9, trans11 conjugated linoleic acid isomer on MCF-7 breast cancer cells are associated with LXR activationA El Roz, J M Bard, J M Huvelin, et al.
Diabetes & Metabolism|October 1, 1996
Serum Lp AI lipoprotein particles and other antiatherogenic lipid parameters in normolipidaemic obese subjectsJ M Lecerf, A Masson, J C Fruchart, et al.
The Journal of Pharmacy and Pharmacology|October 1, 1994
Location of probucol in lipoproteins inferred from compositional analysis of lipoprotein particles. An in-vitro studyJ M Bard, S Urien, J C Fruchart, et al.
Metabolism: Clinical and Experimental|December 12, 2003
Postprandial changes in the distribution of apolipoprotein AIV between apolipoprotein B- and non apolipoprotein B-containing lipoproteins in obese womenF Ferrer, H Nazih, Y Zaïr, et al.
Clinical Chemistry|January 1, 1988
Profiles of apolipoproteins and apolipoprotein B-containing lipoprotein particles in dyslipoproteinemiasP Alaupovic, W J McConathy, J Fesmire, et al.
Pageof 11

Showing results (11-20 of 107) with videos related to

Sort By:
Pageof 11
Clinical Chemistry|June 1, 1993
Sequential ultracentrifugation micromethod for separation of serum lipoproteins and assays of lipids, apolipoproteins, and lipoprotein particlesT Brousseau, V Clavey, J M Bard, et al.
The American Journal of Medicine|June 6, 1994
Fluvastatin reduces levels of plasma apo B-containing particles and increases those of LpA-I. European Fluvastatin Study GroupJ Dallongeville, J C Fruchart, P Pfister, et al.
Journal of Internal Medicine. Supplement|January 1, 1994
Effect of fluvastatin on plasma apolipoprotein-B-containing particles, including lipoprotein(a). European Fluvastatin Study GroupJ Dallongeville, J C Fruchart, P Pfister, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|September 1, 1987
[Molecular analysis of atherogenic and protective lipoproteins]J C Fruchart, J M Bard, C Fievet, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|June 30, 2009
Development and validation of an improved liquid chromatography-mass spectrometry method for the determination of pemetrexed in human plasmaC Bobin-Dubigeon, M B Amiand, C Herrenknecht, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|February 5, 2013
The anti-proliferative and pro-apoptotic effects of the trans9, trans11 conjugated linoleic acid isomer on MCF-7 breast cancer cells are associated with LXR activationA El Roz, J M Bard, J M Huvelin, et al.
Diabetes & Metabolism|October 1, 1996
Serum Lp AI lipoprotein particles and other antiatherogenic lipid parameters in normolipidaemic obese subjectsJ M Lecerf, A Masson, J C Fruchart, et al.
The Journal of Pharmacy and Pharmacology|October 1, 1994
Location of probucol in lipoproteins inferred from compositional analysis of lipoprotein particles. An in-vitro studyJ M Bard, S Urien, J C Fruchart, et al.
Metabolism: Clinical and Experimental|December 12, 2003
Postprandial changes in the distribution of apolipoprotein AIV between apolipoprotein B- and non apolipoprotein B-containing lipoproteins in obese womenF Ferrer, H Nazih, Y Zaïr, et al.
Clinical Chemistry|January 1, 1988
Profiles of apolipoproteins and apolipoprotein B-containing lipoprotein particles in dyslipoproteinemiasP Alaupovic, W J McConathy, J Fesmire, et al.
Pageof 11